17 November 2021
Manchester Biogel and Resnova to sign a strategic agreement for the distribution in Italy of innovative solutions for 3D Cell Culture
Manchester BIOGEL and Resnova are pleased to announce today, their agreement for the exclusive distribution in Italy of fully synthetic scaffold products for 3D cell culture, organoid growth and 3D bioprinting products range. Manchester BIOGEL (MBG), is a British Company...
15 November 2021
Rinicare enters data sharing collaboration with Manchester University NHS Foundation Trust to further develop clinical risk prediction technology
Manchester-based health technology start-up Rinicare has signed a collaboration and data sharing agreement with Manchester University NHS Foundation Trust (MFT) to further develop its advanced clinical risk prediction technology platform, STABILITY. Rinicare’s clinical...
10 November 2021
Trio Healthcare takes leap forward in international growth strategy by opening first office in US
Trio Healthcare has made a significant step forward in its international growth strategy by opening its first office in the US. The team will be established in Princeton, New Jersey, and the move marks the first time the company will have a direct sales presence in the lucrative...
2 November 2021
Biofortuna relocates to purpose built facilities and more than doubles its capacity
Biofortuna, a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales. The purpose-built...
1 November 2021
Panthera@theRutherford partnership commences first UK multicentre oncology trial in prostate cancer
Panthera@theRutherford clinical trial partnership has commenced the first UK multicentre oncology trial in prostate cancer with ten more oncology trials in the pipeline … The first multisite oncology trial undertaken by the independent sector in the UK has started treating its...
27 October 2021
ADEPT study proves value of dental AI using AssistDent® AI software
Article taken from Dental Review News 26th October 2021: https://www.dentalreview.news/technology/24-dental-cad-cam-technology/7922-adept-study-proves-value-of-dental-ai … A spokesperson for the University of Manchester Dental School’s ADEPT (AssistDent Enamel-only...
25 October 2021
Rinicare confirms first European evaluation of its AI falls prevention technology
Manchester-based MedTech start-up Rinicare is working with Odense University Hospital in Denmark on a product evaluation of its unique falls reduction technology solution, SAFE. The Odense University Hospital team will evaluate the extent to which the SAFE platform (System to...
6 October 2021
Channel 4 Ventures invests in Maxwellia to support the launch of Lovima®
Maxwellia has announced a major investment from Channel 4 Ventures, striking an airtime-for-equity arrangement. The new investment will support the marketing campaign for Lovima®, helping fund a hugely impactful, innovative and educational 360° campaign designed to raise...
30 September 2021
Maxwellia announces appointment of Sara Al-Attbi as Medical Affairs Pharmacist
Maxwellia, the UK’s only company 100% dedicated to switching Rx to OTC medicines, has appointed Sara Al-Attbi to the newly created role of Medical Affairs Pharmacist. The role reflects Maxwellia’s focus on and commitment to widening access to medicines through...
22 September 2021
Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease
21 September 2021: Piscataway, New Jersey; Oxford and Manchester, UK; Mahwah, New Jersey. Today, Infinity BiologiX, LLC (IBX), Cytox Ltd, and Vanguard Pharma announce the launch of the IBX Alzheimer’s Risk Test, powered by genoSCORETM. Physicians are able to pre-register...